A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: the design of the GEMINI-ACS-1 phase II study

Povsic, TJ; Roe, MT; Ohman, EM; Steg, PG; James, S; Plotnikov, A; Mundl, H; Welsh, R; Bode, C; Gibson, CM

doi:https://www.dx.doi.org/10.1016/j.ahj.2016.01.004

File(s)

GEMINI DesignManuscript_AHJ_revision 12_08_15 clean.docx (263.86 KB)

Accepted version

1-s2.0-S0002870316000156-main.pdf (503.66 KB)

Published version

Author(s)

Povsic, TJ

Roe, MT

Ohman, EM

Steg, PG

James, S

more

Type

Journal Article

Date Issued

2016-01-18

Date Acceptance

2016-01-15

Citation

American Heart Journal, 2016, 174, pp.120-128

URI

http://hdl.handle.net/10044/1/31484

DOI

https://www.dx.doi.org/10.1016/j.ahj.2016.01.004

ISSN

1097-6744

Publisher

Elsevier

Start Page

120

End Page

128

Journal / Book Title

American Heart Journal

Volume

174

Copyright Statement

© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

License URL

http://creativecommons.org/licenses/by-nc-nd/4.0/

Identifier

PII: S0002-8703(16)00015-6

Subjects

Cardiovascular System & Hematology

1102 Cardiovascular Medicine And Haematology

1117 Public Health And Health Services

Publication Status

Published